Iovance Biotherapeutics, Inc. (IOVA)
4.11
+0.41
(+11.08%)
USD |
NASDAQ |
May 22, 16:00
4.06
-0.05
(-1.22%)
After-Hours: 20:00
Iovance Biotherapeutics EPS Diluted (Quarterly) : -0.1889 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANIKA THERAPEUTICS INC | -0.3737 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Plus Therapeutics, Inc. | -1.045 |
| Perspective Therapeutics, Inc. | -0.2528 |
| AVITA Medical, Inc. | -0.3474 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -79.04M |
| Revenue (Quarterly) | 71.43M |
| Total Expenses (Quarterly) | 150.48M |
| Enterprise Value | 1.569B |
| Gross Profit Margin (Quarterly) | 28.55% |
| Profit Margin (Quarterly) | -110.7% |
| Earnings Yield | -23.12% |
| Normalized Earnings Yield | -22.87 |